140 related articles for article (PubMed ID: 8544041)
1. In vivo study of artemisinin and its derivatives against primary amebic meningoencephalitis caused by Naegleria fowleri.
Gupta S; Ghosh PK; Dutta GP; Vishwakarma RA
J Parasitol; 1995 Dec; 81(6):1012-3. PubMed ID: 8544041
[TBL] [Abstract][Full Text] [Related]
2. Effect of alpha,beta-arteether against primary amoebic meningoencephalitis in Swiss mice.
Gupta S; Dutta GP; Vishwakarma RA
Indian J Exp Biol; 1998 Aug; 36(8):824-5. PubMed ID: 9838887
[TBL] [Abstract][Full Text] [Related]
3. Primary amoebic meningoencephalitis with Naegleria fowleri: clinical review.
Barnett ND; Kaplan AM; Hopkin RJ; Saubolle MA; Rudinsky MF
Pediatr Neurol; 1996 Oct; 15(3):230-4. PubMed ID: 8916161
[TBL] [Abstract][Full Text] [Related]
4. Successful treatment of Naegleria fowleri meningoencephalitis by using intravenous amphotericin B, fluconazole and rifampicin.
Vargas-Zepeda J; Gómez-Alcalá AV; Vásquez-Morales JA; Licea-Amaya L; De Jonckheere JF; Lares-Villa F
Arch Med Res; 2005; 36(1):83-6. PubMed ID: 15900627
[TBL] [Abstract][Full Text] [Related]
5. Primary amoebic meningoencephalitis in an infant.
Mittal N; Mahajan L; Hussain Z; Gupta P; Khurana S
Indian J Med Microbiol; 2019; 37(1):120-122. PubMed ID: 31424023
[TBL] [Abstract][Full Text] [Related]
6. Survival of Naegleria fowleri primary amebic meningocephalitis (PAM) could be improved with an intensive multi-route chemo- and biotherapeutic regimen.
Alisky JM
Med Hypotheses; 2008 Dec; 71(6):969-71. PubMed ID: 18715722
[TBL] [Abstract][Full Text] [Related]
7. Effect of therapeutic chemical agents in vitro and on experimental meningoencephalitis due to Naegleria fowleri.
Kim JH; Jung SY; Lee YJ; Song KJ; Kwon D; Kim K; Park S; Im KI; Shin HJ
Antimicrob Agents Chemother; 2008 Nov; 52(11):4010-6. PubMed ID: 18765686
[TBL] [Abstract][Full Text] [Related]
8. Activities of therapeutic agents against Naegleria fowleri in vitro and in a mouse model of primary amebic meningoencephalitis.
Goswick SM; Brenner GM
J Parasitol; 2003 Aug; 89(4):837-42. PubMed ID: 14533700
[TBL] [Abstract][Full Text] [Related]
9. Activities of azithromycin and amphotericin B against Naegleria fowleri in vitro and in a mouse model of primary amebic meningoencephalitis.
Goswick SM; Brenner GM
Antimicrob Agents Chemother; 2003 Feb; 47(2):524-8. PubMed ID: 12543653
[TBL] [Abstract][Full Text] [Related]
10. Fatal primary meningoencephalitis caused by Naegleria fowleri.
Shariq A; Afridi FI; Farooqi BJ; Ahmed S; Hussain A
J Coll Physicians Surg Pak; 2014 Jul; 24(7):523-5. PubMed ID: 25052979
[TBL] [Abstract][Full Text] [Related]
11. Synergistic activities of azithromycin and amphotericin B against Naegleria fowleri in vitro and in a mouse model of primary amebic meningoencephalitis.
Soltow SM; Brenner GM
Antimicrob Agents Chemother; 2007 Jan; 51(1):23-7. PubMed ID: 17060522
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic effect of rokitamycin in vitro and on experimental meningoencephalitis due to Naegleria fowleri.
Kim JH; Lee YJ; Sohn HJ; Song KJ; Kwon D; Kwon MH; Im KI; Shin HJ
Int J Antimicrob Agents; 2008 Nov; 32(5):411-7. PubMed ID: 18762406
[TBL] [Abstract][Full Text] [Related]
13. Naegleria meningitis: a rare survival.
Jain R; Prabhakar S; Modi M; Bhatia R; Sehgal R
Neurol India; 2002 Dec; 50(4):470-2. PubMed ID: 12577098
[TBL] [Abstract][Full Text] [Related]
14. Activity of Auranofin against Multiple Genotypes of
Escrig JI; Hahn HJ; Debnath A
ACS Chem Neurosci; 2020 Aug; 11(16):2464-2471. PubMed ID: 32392039
[TBL] [Abstract][Full Text] [Related]
15. Primary amoebic meningoencephalitis caused by Naegleria. Two new cases, response to amphotericin B, and a review.
Duma RJ; Rosenblum WI; McGehee RF; Jones MM; Nelson EC
Ann Intern Med; 1971 Jun; 74(6):923-31. PubMed ID: 5580639
[No Abstract] [Full Text] [Related]
16. Primary amoebic meningoencephalitis: two new cases from Pakistan.
Saleem T; Rabbani M; Jamil B
Trop Doct; 2009 Oct; 39(4):242-3. PubMed ID: 19671781
[TBL] [Abstract][Full Text] [Related]
17. Primary amebic meningoencephalitis.
Darby CP; Conradi SE; Holbrook TW; Chatellier C
Am J Dis Child; 1979 Oct; 133(10):1025-7. PubMed ID: 495593
[TBL] [Abstract][Full Text] [Related]
18. Corifungin, a new drug lead against Naegleria, identified from a high-throughput screen.
Debnath A; Tunac JB; Galindo-Gómez S; Silva-Olivares A; Shibayama M; McKerrow JH
Antimicrob Agents Chemother; 2012 Nov; 56(11):5450-7. PubMed ID: 22869574
[TBL] [Abstract][Full Text] [Related]
19. Successful treatment of primary amebic meningoencephalitis.
Brown RL
Arch Intern Med; 1991 Jun; 151(6):1201-2. PubMed ID: 2043022
[TBL] [Abstract][Full Text] [Related]
20. Effects of cyclophosphamide and a metabolite, acrolein, on Naegleria fowleri in vitro and in vivo.
Zhang L; Marciano-Cabral F; Bradley SG
Antimicrob Agents Chemother; 1988 Jul; 32(7):962-5. PubMed ID: 3190198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
